Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan R Robinson

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Cancer Research|December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCostanza Paoletti, Andi K Cani, Jose M Larios, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2020
Targeting transcriptional regulation of SARS-CoV-2 entry factors <i>ACE2</i> and <i>TMPRSS2</i>Yuanyuan Qiao, Xiao-Ming Wang, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Cancer Research|December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCostanza Paoletti, Andi K Cani, Jose M Larios, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2020
Targeting transcriptional regulation of SARS-CoV-2 entry factors <i>ACE2</i> and <i>TMPRSS2</i>Yuanyuan Qiao, Xiao-Ming Wang, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Pageof 6